New & Noteworthy

Submit New & Noteworthy

January 2021

High-Throughput SARS-CoV-2 and Flu Panel

Agena Bioscience, Inc

The MassARRAY SARS-CoV-2/Flu Panel from Agena Bioscience is a scalable, low-cost platform for qualitative and simultaneous detection of SARS-CoV-2, influenza A, and influenza B RNA, based on reverse transcriptase PCR (RT-PCR). The high-throughput capability can help laboratories process thousands of samples per day, which can free up staff time and resources. Additionally, access to reliable testing helps to streamline larger sample volumes.
The panel aims to ensure accurate detection by including dual SARS-CoV-2 targets for redundancy, and its pan-assay design detects all influenza A subtypes (including H1N1 and H3N2) and influenza B lineages. Agena aims to secure a reliable supply, with immediate availability of instruments and reagents.

Agena Bioscience

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: